The Gabelli Healthcare & Wellness Trust (NYSE:GRX) Major Shareholder Acquires 1,203 Shares of Stock

The Gabelli Healthcare & Wellness Trust (NYSE:GRX) major shareholder Saba Capital Management, L.P. acquired 1,203 shares of the firm’s stock in a transaction that occurred on Friday, August 14th. The stock was purchased at an average cost of $9.86 per share, with a total value of $11,861.58. Following the purchase, the insider directly owned 2,119,604 shares in the company, valued at approximately $20,899,295.44. This trade represents a 0.06% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Tuesday, August 11th, Saba Capital Management, L.P. bought 200 shares of The Gabelli Healthcare & Wellness Trust stock. The shares were purchased at an average cost of $9.93 per share, for a total transaction of $1,986.00.

The Gabelli Healthcare & Wellness Trust Price Performance

Shares of GRX traded down $0.03 during mid-day trading on Monday, reaching $9.89. The company’s stock had a trading volume of 4,012 shares, compared to its average volume of 26,995. The business has a fifty day moving average of $9.50 and a 200 day moving average of $9.39. The Gabelli Healthcare & Wellness Trust has a 1 year low of $8.80 and a 1 year high of $10.05.

The Gabelli Healthcare & Wellness Trust Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Wednesday, September 16th will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 6.9%. The ex-dividend date of this dividend is Wednesday, September 16th.

Institutional Investors Weigh In On The Gabelli Healthcare & Wellness Trust

A number of institutional investors have recently bought and sold shares of GRX. Osaic Holdings Inc. increased its holdings in shares of The Gabelli Healthcare & Wellness Trust by 11.3% in the 2nd quarter. Osaic Holdings Inc. now owns 28,443 shares of the investment management company’s stock valued at $269,000 after purchasing an additional 2,880 shares during the period. Raymond James Financial Inc. boosted its holdings in shares of The Gabelli Healthcare & Wellness Trust by 83.9% during the third quarter. Raymond James Financial Inc. now owns 30,974 shares of the investment management company’s stock worth $281,000 after purchasing an additional 14,132 shares during the period. International Assets Investment Management LLC acquired a new stake in shares of The Gabelli Healthcare & Wellness Trust during the fourth quarter worth approximately $77,000. Gamco Investors INC. ET AL grew its position in The Gabelli Healthcare & Wellness Trust by 9.6% during the fourth quarter. Gamco Investors INC. ET AL now owns 342,226 shares of the investment management company’s stock valued at $3,296,000 after purchasing an additional 30,000 shares in the last quarter. Finally, Aviance Capital Partners LLC grew its position in The Gabelli Healthcare & Wellness Trust by 2.5% during the fourth quarter. Aviance Capital Partners LLC now owns 167,843 shares of the investment management company’s stock valued at $1,616,000 after purchasing an additional 4,164 shares in the last quarter.

About The Gabelli Healthcare & Wellness Trust

The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a closed-end management investment company that seeks both capital appreciation and current income. The trust primarily invests in equity and equity-related securities of companies operating in the healthcare and wellness sectors. Trading on the New York Stock Exchange under the symbol GRX, the fund provides investors with exposure to growth opportunities in healthcare through its closed-end structure.

The trust’s portfolio is diversified across a broad range of healthcare sub-industries, including pharmaceuticals, biotechnology, medical devices, and healthcare services.